Please enable JavaScript to continue using this application.

Compare $CYDY vs $VNDA | Chartloom

Compare

$CYDY vs $VNDA

Cytodyn Inc · Vanda Pharmaceuticals Inc

CYDY

Cytodyn Inc

VNDA

Vanda Pharmaceuticals Inc

Compare $CYDY vs $VNDA

Comparing Cytodyn Inc and Vanda Pharmaceuticals Inc

CYDYCytodyn Inc

VNDAVanda Pharmaceuticals Inc

CYDYCytodyn Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.2%

FCF yield

-6.3%

VNDAVanda Pharmaceuticals Inc

Market cap

$275M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.89x

Rev growth (TTM)

6.0%

YTD performance

-44.6%

52W performance

-16.3%

FCF yield

-55.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYDY

VNDA

Detailed metrics comparison

CYDY

Cytodyn Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

CYDY$274M

VNDA$275M

Enterprise Value

CYDY$289M

VNDA$226M

Price

CYDY$0.20

VNDA$4.57

P/E Ratio

CYDYN/A

VNDAN/A

P/S Ratio

CYDY0.00x

VNDA1.27x

EV/Sales

CYDY0.00x

VNDA1.05x

EV/EBITDA

CYDY34.72x

VNDA183.49x

P/B Ratio

CYDY106.18x

VNDA1.29x

P/FCF Ratio

CYDYN/A

VNDAN/A

EV/FCF

CYDY-16.77x

VNDA-1.48x

PEG Ratio

CYDYN/A

VNDAN/A

Forward P/E (NTM)

CYDYN/A

VNDAN/A

Forward P/S (NTM)

CYDYN/A

VNDA0.89x

Revenue (TTM)

CYDY$0

VNDA$216M

Revenue Growth (YoY)

CYDYN/A

VNDA6.0%

Forward Rev Growth

CYDY0.0%

VNDA35.6%

Gross Margin (TTM)

CYDY0.0%

VNDA93.7%

Operating Margin (TTM)

CYDY0.0%

VNDA0.0%

EBITDA Margin (TTM)

CYDY0.0%

VNDA-82.1%

Net Margin (TTM)

CYDY0.0%

VNDA-127.4%

FCF Margin (TTM)

CYDYN/A

VNDA-70.9%

Net Income (TTM)

CYDY$-44M

VNDA$-275M

FCF (TTM)

CYDY$-17M

VNDA$-153M

EPS (TTM)

CYDY-$0.03

VNDA-$4.56

ROE (TTM)

CYDY-111387.0%

VNDA-8495.0%

ROA (TTM)

CYDY-31117.0%

VNDA-5679.0%

ROIC (TTM)

CYDY-8873.0%

VNDA-8320.0%

Cash

CYDY$12M

VNDA$56M

Debt

CYDY$27M

VNDA$7M

Net Cash/Debt

CYDY$-15M

VNDA$49M

Current Ratio (TTM)

CYDY0.26x

VNDA1.61x

Quick Ratio (TTM)

CYDY0.22x

VNDA1.40x

Debt/Equity (TTM)

CYDY11.55x

VNDA0.03x

Debt/Assets (TTM)

CYDY0.0%

VNDA0.0%

Interest Coverage (TTM)

CYDYN/A

VNDAN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

VNDA0.00x

Beta

CYDY1.76

VNDA0.69

52W Performance

CYDY-24.2%

VNDA-16.3%

YTD Performance

CYDY-26.0%

VNDA-44.6%

% from 52W High

CYDY-49.6%

VNDA-54.0%

% from 52W Low

CYDY9.3%

VNDA7.0%

Asset Turnover (TTM)

CYDY0.00x

VNDA0.45x

FCF Yield (TTM)

CYDY-6.3%

VNDA-55.7%

Earnings Yield (TTM)

CYDY-16.1%

VNDA-100.0%

Dividend Yield (TTM)

CYDYN/A

VNDAN/A

Rule of 40

CYDY0.0

VNDA-64.9

EV/GP/RG

CYDYN/A

VNDA0.01

Ticker research

View CYDY research View VNDA research

Metric	CYDY Cytodyn Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$274M	$275M
Enterprise Value	$289M	$226M
Price	$0.20	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.27x
EV/Sales	0.00x	1.05x
EV/EBITDA	34.72x	183.49x
P/B Ratio	106.18x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.89x
Revenue & Growth
Revenue (TTM)	$0	$216M
Revenue Growth (YoY)	N/A	6.0%
Forward Rev Growth	0.0%	35.6%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-82.1%
Net Margin (TTM)	0.0%	-127.4%
FCF Margin (TTM)	N/A	-70.9%
Net Income (TTM)	$-44M	$-275M
FCF (TTM)	$-17M	$-153M
EPS (TTM)	-$0.03	-$4.56
ROE (TTM)	-111387.0%	-8495.0%
ROA (TTM)	-31117.0%	-5679.0%
ROIC (TTM)	-8873.0%	-8320.0%
Financial Health
Cash	$12M	$56M
Debt	$27M	$7M
Net Cash/Debt	$-15M	$49M
Current Ratio (TTM)	0.26x	1.61x
Quick Ratio (TTM)	0.22x	1.40x
Debt/Equity (TTM)	11.55x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.69
52W Performance	-24.2%	-16.3%
YTD Performance	-26.0%	-44.6%
% from 52W High	-49.6%	-54.0%
% from 52W Low	9.3%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-6.3%	-55.7%
Earnings Yield (TTM)	-16.1%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-64.9
EV/GP/RG	N/A	0.01
Ticker research	View CYDY research	View VNDA research

Valuation

P/S Ratio

CYDY

0.00x

VNDA

1.27x

EV/FCF

CYDY

-16.77x

VNDA

-1.48x

Growth & revenue

Revenue Growth TTM

VNDA

6.0%

Forward Revenue Growth

VNDA

35.6%

CYDY

0.0%

Profitability & performance

Gross Margin

VNDA

93.7%

CYDY

0.0%

ROE

VNDA

-8495.0%

CYDY

-111387.0%

FCF Yield %

CYDY

-6.3%

VNDA

-55.7%

52-Week Performance

VNDA

-16.3%

CYDY

-24.2%

Detailed metrics comparison

CYDY

Cytodyn Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

CYDY$274M

VNDA$275M

Enterprise Value

CYDY$289M

VNDA$226M

Price

CYDY$0.20

VNDA$4.57

P/E Ratio

CYDYN/A

VNDAN/A

P/S Ratio

CYDY0.00x

VNDA1.27x

EV/Sales

CYDY0.00x

VNDA1.05x

EV/EBITDA

CYDY34.72x

VNDA183.49x

P/B Ratio

CYDY106.18x

VNDA1.29x

P/FCF Ratio

CYDYN/A

VNDAN/A

EV/FCF

CYDY-16.77x

VNDA-1.48x

PEG Ratio

CYDYN/A

VNDAN/A

Forward P/E (NTM)

CYDYN/A

VNDAN/A

Forward P/S (NTM)

CYDYN/A

VNDA0.89x

Revenue (TTM)

CYDY$0

VNDA$216M

Revenue Growth (YoY)

CYDYN/A

VNDA6.0%

Forward Rev Growth

CYDY0.0%

VNDA35.6%

Gross Margin (TTM)

CYDY0.0%

VNDA93.7%

Operating Margin (TTM)

CYDY0.0%

VNDA0.0%

EBITDA Margin (TTM)

CYDY0.0%

VNDA-82.1%

Net Margin (TTM)

CYDY0.0%

VNDA-127.4%

FCF Margin (TTM)

CYDYN/A

VNDA-70.9%

Net Income (TTM)

CYDY$-44M

VNDA$-275M

FCF (TTM)

CYDY$-17M

VNDA$-153M

EPS (TTM)

CYDY-$0.03

VNDA-$4.56

ROE (TTM)

CYDY-111387.0%

VNDA-8495.0%

ROA (TTM)

CYDY-31117.0%

VNDA-5679.0%

ROIC (TTM)

CYDY-8873.0%

VNDA-8320.0%

Cash

CYDY$12M

VNDA$56M

Debt

CYDY$27M

VNDA$7M

Net Cash/Debt

CYDY$-15M

VNDA$49M

Current Ratio (TTM)

CYDY0.26x

VNDA1.61x

Quick Ratio (TTM)

CYDY0.22x

VNDA1.40x

Debt/Equity (TTM)

CYDY11.55x

VNDA0.03x

Debt/Assets (TTM)

CYDY0.0%

VNDA0.0%

Interest Coverage (TTM)

CYDYN/A

VNDAN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

VNDA0.00x

Beta

CYDY1.76

VNDA0.69

52W Performance

CYDY-24.2%

VNDA-16.3%

YTD Performance

CYDY-26.0%

VNDA-44.6%

% from 52W High

CYDY-49.6%

VNDA-54.0%

% from 52W Low

CYDY9.3%

VNDA7.0%

Asset Turnover (TTM)

CYDY0.00x

VNDA0.45x

FCF Yield (TTM)

CYDY-6.3%

VNDA-55.7%

Earnings Yield (TTM)

CYDY-16.1%

VNDA-100.0%

Dividend Yield (TTM)

CYDYN/A

VNDAN/A

Rule of 40

CYDY0.0

VNDA-64.9

EV/GP/RG

CYDYN/A

VNDA0.01

Ticker research

View CYDY research View VNDA research

Metric	CYDY Cytodyn Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$274M	$275M
Enterprise Value	$289M	$226M
Price	$0.20	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.27x
EV/Sales	0.00x	1.05x
EV/EBITDA	34.72x	183.49x
P/B Ratio	106.18x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.89x
Revenue & Growth
Revenue (TTM)	$0	$216M
Revenue Growth (YoY)	N/A	6.0%
Forward Rev Growth	0.0%	35.6%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-82.1%
Net Margin (TTM)	0.0%	-127.4%
FCF Margin (TTM)	N/A	-70.9%
Net Income (TTM)	$-44M	$-275M
FCF (TTM)	$-17M	$-153M
EPS (TTM)	-$0.03	-$4.56
ROE (TTM)	-111387.0%	-8495.0%
ROA (TTM)	-31117.0%	-5679.0%
ROIC (TTM)	-8873.0%	-8320.0%
Financial Health
Cash	$12M	$56M
Debt	$27M	$7M
Net Cash/Debt	$-15M	$49M
Current Ratio (TTM)	0.26x	1.61x
Quick Ratio (TTM)	0.22x	1.40x
Debt/Equity (TTM)	11.55x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.69
52W Performance	-24.2%	-16.3%
YTD Performance	-26.0%	-44.6%
% from 52W High	-49.6%	-54.0%
% from 52W Low	9.3%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-6.3%	-55.7%
Earnings Yield (TTM)	-16.1%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-64.9
EV/GP/RG	N/A	0.01
Ticker research	View CYDY research	View VNDA research